---
keywords:
  - Graph Neural Network
  - Attention Mechanism
  - Multi-Scale Representation
  - Uncertainty Estimation
category: cs.AI
publish_date: 2025-09-22
arxiv_id: 2509.15256
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-23T08:50:04.071999",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Graph Neural Network",
    "Attention Mechanism",
    "Multi-Scale Representation",
    "Uncertainty Estimation"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Graph Neural Network": 0.82,
    "Attention Mechanism": 0.85,
    "Multi-Scale Representation": 0.78,
    "Uncertainty Estimation": 0.79
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Graph Neural Process",
        "canonical": "Graph Neural Network",
        "aliases": [
          "GNP"
        ],
        "category": "specific_connectable",
        "rationale": "This concept extends Graph Neural Networks by incorporating process-based learning, enhancing connectivity with existing graph-based models.",
        "novelty_score": 0.65,
        "connectivity_score": 0.85,
        "specificity_score": 0.78,
        "link_intent_score": 0.82
      },
      {
        "surface": "Cross-Drug Co-Attention",
        "canonical": "Attention Mechanism",
        "aliases": [
          "Drug Co-Attention"
        ],
        "category": "specific_connectable",
        "rationale": "This mechanism is a specialized form of attention, facilitating connections with other attention-based models.",
        "novelty_score": 0.7,
        "connectivity_score": 0.88,
        "specificity_score": 0.8,
        "link_intent_score": 0.85
      },
      {
        "surface": "Multi-Scale Representation",
        "canonical": "Multi-Scale Representation",
        "aliases": [
          "Hierarchical Representation"
        ],
        "category": "unique_technical",
        "rationale": "Captures structural information across scales, crucial for linking to hierarchical data processing techniques.",
        "novelty_score": 0.68,
        "connectivity_score": 0.75,
        "specificity_score": 0.77,
        "link_intent_score": 0.78
      },
      {
        "surface": "Uncertainty Estimation",
        "canonical": "Uncertainty Estimation",
        "aliases": [
          "Prediction Confidence"
        ],
        "category": "unique_technical",
        "rationale": "Provides a mechanism for evaluating prediction reliability, linking to probabilistic modeling approaches.",
        "novelty_score": 0.72,
        "connectivity_score": 0.7,
        "specificity_score": 0.76,
        "link_intent_score": 0.79
      }
    ],
    "ban_list_suggestions": [
      "drug-drug interactions",
      "medication safety",
      "effective drug development"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Graph Neural Process",
      "resolved_canonical": "Graph Neural Network",
      "decision": "linked",
      "scores": {
        "novelty": 0.65,
        "connectivity": 0.85,
        "specificity": 0.78,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "Cross-Drug Co-Attention",
      "resolved_canonical": "Attention Mechanism",
      "decision": "linked",
      "scores": {
        "novelty": 0.7,
        "connectivity": 0.88,
        "specificity": 0.8,
        "link_intent": 0.85
      }
    },
    {
      "candidate_surface": "Multi-Scale Representation",
      "resolved_canonical": "Multi-Scale Representation",
      "decision": "linked",
      "scores": {
        "novelty": 0.68,
        "connectivity": 0.75,
        "specificity": 0.77,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "Uncertainty Estimation",
      "resolved_canonical": "Uncertainty Estimation",
      "decision": "linked",
      "scores": {
        "novelty": 0.72,
        "connectivity": 0.7,
        "specificity": 0.76,
        "link_intent": 0.79
      }
    }
  ]
}
-->

# A Multi-Scale Graph Neural Process with Cross-Drug Co-Attention for Drug-Drug Interactions Prediction

**Korean Title:** ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ê·¸ë˜í”„ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ì™€ êµì°¨ ì•½ë¬¼ ê³µë™ ì£¼ì˜ë¥¼ í™œìš©í•œ ì•½ë¬¼ ìƒí˜¸ì‘ìš© ì˜ˆì¸¡

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250922|20250922]] [[categories/cs.AI|cs.AI]]
**PDF**: [Download](https://arxiv.org/pdf/2509.15256.pdf)
**Category**: cs.AI
**Published**: 2025-09-22
**ArXiv ID**: [2509.15256](https://arxiv.org/abs/2509.15256)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-18/Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery_20250918|Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery]] (83.0% similar)
- [[2025-09-22/Detail Across Scales_ Multi-Scale Enhancement for Full Spectrum Neural Representations_20250922|Detail Across Scales: Multi-Scale Enhancement for Full Spectrum Neural Representations]] (79.2% similar)
- [[2025-09-22/PBPK-iPINNs_ Inverse Physics-Informed Neural Networks for Physiologically Based Pharmacokinetic Brain Models_20250922|PBPK-iPINNs: Inverse Physics-Informed Neural Networks for Physiologically Based Pharmacokinetic Brain Models]] (78.8% similar)
- [[2025-09-18/Locally Explaining Prediction Behavior via Gradual Interventions and Measuring Property Gradients_20250918|Locally Explaining Prediction Behavior via Gradual Interventions and Measuring Property Gradients]] (77.8% similar)
- [[2025-09-19/DINAMO_ Dynamic and INterpretable Anomaly MOnitoring for Large-Scale Particle Physics Experiments_20250919|DINAMO: Dynamic and INterpretable Anomaly MOnitoring for Large-Scale Particle Physics Experiments]] (77.7% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Graph Neural Network|Graph Neural Network]], [[keywords/Attention Mechanism|Attention Mechanism]]
**âš¡ Unique Technical**: [[keywords/Multi-Scale Representation|Multi-Scale Representation]], [[keywords/Uncertainty Estimation|Uncertainty Estimation]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.15256v1 Announce Type: cross 
Abstract: Accurate prediction of drug-drug interactions (DDI) is crucial for medication safety and effective drug development. However, existing methods often struggle to capture structural information across different scales, from local functional groups to global molecular topology, and typically lack mechanisms to quantify prediction confidence. To address these limitations, we propose MPNP-DDI, a novel Multi-scale Graph Neural Process framework. The core of MPNP-DDI is a unique message-passing scheme that, by being iteratively applied, learns a hierarchy of graph representations at multiple scales. Crucially, a cross-drug co-attention mechanism then dynamically fuses these multi-scale representations to generate context-aware embeddings for interacting drug pairs, while an integrated neural process module provides principled uncertainty estimation. Extensive experiments demonstrate that MPNP-DDI significantly outperforms state-of-the-art baselines on benchmark datasets. By providing accurate, generalizable, and uncertainty-aware predictions built upon multi-scale structural features, MPNP-DDI represents a powerful computational tool for pharmacovigilance, polypharmacy risk assessment, and precision medicine.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

arXiv:2509.15256v1 ë°œí‘œ ìœ í˜•: êµì°¨  
ì´ˆë¡: ì•½ë¬¼ ê°„ ìƒí˜¸ì‘ìš©(DDI)ì˜ ì •í™•í•œ ì˜ˆì¸¡ì€ ì•½ë¬¼ ì•ˆì „ì„±ê³¼ íš¨ê³¼ì ì¸ ì•½ë¬¼ ê°œë°œì— í•„ìˆ˜ì ì…ë‹ˆë‹¤. ê·¸ëŸ¬ë‚˜ ê¸°ì¡´ ë°©ë²•ë“¤ì€ ì¢…ì¢… ì§€ì—­ì  ê¸°ëŠ¥ ê·¸ë£¹ì—ì„œ ì „ì—­ ë¶„ì ìœ„ìƒì— ì´ë¥´ê¸°ê¹Œì§€ ë‹¤ì–‘í•œ ê·œëª¨ì˜ êµ¬ì¡°ì  ì •ë³´ë¥¼ í¬ì°©í•˜ëŠ” ë° ì–´ë ¤ì›€ì„ ê²ªìœ¼ë©°, ì¼ë°˜ì ìœ¼ë¡œ ì˜ˆì¸¡ ì‹ ë¢°ë„ë¥¼ ì •ëŸ‰í™”í•  ìˆ˜ ìˆëŠ” ë©”ì»¤ë‹ˆì¦˜ì´ ë¶€ì¡±í•©ë‹ˆë‹¤. ì´ëŸ¬í•œ í•œê³„ë¥¼ ê·¹ë³µí•˜ê¸° ìœ„í•´, ìš°ë¦¬ëŠ” MPNP-DDIë¼ëŠ” ìƒˆë¡œìš´ ë‹¤ì¤‘ ê·œëª¨ ê·¸ë˜í”„ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ í”„ë ˆì„ì›Œí¬ë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. MPNP-DDIì˜ í•µì‹¬ì€ ë°˜ë³µì ìœ¼ë¡œ ì ìš©ë˜ì–´ ì—¬ëŸ¬ ê·œëª¨ì—ì„œ ê·¸ë˜í”„ í‘œí˜„ì˜ ê³„ì¸µì„ í•™ìŠµí•˜ëŠ” ë…íŠ¹í•œ ë©”ì‹œì§€ ì „ë‹¬ ë°©ì‹ì…ë‹ˆë‹¤. ì¤‘ìš”í•œ ê²ƒì€, êµì°¨ ì•½ë¬¼ ê³µë™ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì´ ì´ëŸ¬í•œ ë‹¤ì¤‘ ê·œëª¨ í‘œí˜„ì„ ë™ì ìœ¼ë¡œ ìœµí•©í•˜ì—¬ ìƒí˜¸ì‘ìš©í•˜ëŠ” ì•½ë¬¼ ìŒì— ëŒ€í•œ ë§¥ë½ ì¸ì‹ ì„ë² ë”©ì„ ìƒì„±í•˜ë©°, í†µí•©ëœ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ ëª¨ë“ˆì€ ì›ì¹™ì ì¸ ë¶ˆí™•ì‹¤ì„± ì¶”ì •ì„ ì œê³µí•©ë‹ˆë‹¤. ê´‘ë²”ìœ„í•œ ì‹¤í—˜ ê²°ê³¼, MPNP-DDIê°€ ë²¤ì¹˜ë§ˆí¬ ë°ì´í„°ì…‹ì—ì„œ ìµœì²¨ë‹¨ ê¸°ì¤€ ëª¨ë¸ë“¤ì„ í¬ê²Œ ëŠ¥ê°€í•¨ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. ë‹¤ì¤‘ ê·œëª¨ êµ¬ì¡°ì  íŠ¹ì§•ì— ê¸°ë°˜í•˜ì—¬ ì •í™•í•˜ê³  ì¼ë°˜í™” ê°€ëŠ¥í•˜ë©° ë¶ˆí™•ì‹¤ì„±ì„ ì¸ì‹í•˜ëŠ” ì˜ˆì¸¡ì„ ì œê³µí•¨ìœ¼ë¡œì¨, MPNP-DDIëŠ” ì•½ë¬¼ ê°ì‹œ, ë‹¤ì•½ì œ ìœ„í—˜ í‰ê°€, ì •ë°€ ì˜í•™ì„ ìœ„í•œ ê°•ë ¥í•œ ê³„ì‚° ë„êµ¬ë¥¼ ëŒ€í‘œí•©ë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì•½ë¬¼ ìƒí˜¸ì‘ìš©(DDI) ì˜ˆì¸¡ì˜ ì •í™•ì„±ì„ ë†’ì´ê¸° ìœ„í•´ MPNP-DDIë¼ëŠ” ìƒˆë¡œìš´ ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ê·¸ë˜í”„ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ í”„ë ˆì„ì›Œí¬ë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. MPNP-DDIëŠ” ë…íŠ¹í•œ ë©”ì‹œì§€ ì „ë‹¬ ë°©ì‹ì„ í†µí•´ ì—¬ëŸ¬ ìŠ¤ì¼€ì¼ì—ì„œ ê·¸ë˜í”„ í‘œí˜„ì„ í•™ìŠµí•˜ë©°, êµì°¨ ì•½ë¬¼ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì„ í†µí•´ ìƒí˜¸ì‘ìš©í•˜ëŠ” ì•½ë¬¼ ìŒì˜ ë¬¸ë§¥ ì¸ì‹ ì„ë² ë”©ì„ ìƒì„±í•©ë‹ˆë‹¤. ë˜í•œ, í†µí•©ëœ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ ëª¨ë“ˆì„ í†µí•´ ì˜ˆì¸¡ì˜ ë¶ˆí™•ì‹¤ì„±ì„ ì •ëŸ‰í™”í•©ë‹ˆë‹¤. ì‹¤í—˜ ê²°ê³¼, MPNP-DDIëŠ” ê¸°ì¡´ ë°©ë²•ë“¤ë³´ë‹¤ ë›°ì–´ë‚œ ì„±ëŠ¥ì„ ë³´ì˜€ìœ¼ë©°, ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ êµ¬ì¡°ì  íŠ¹ì§•ì„ ê¸°ë°˜ìœ¼ë¡œ ì •í™•í•˜ê³  ì¼ë°˜í™” ê°€ëŠ¥í•˜ë©° ë¶ˆí™•ì‹¤ì„±ì„ ê³ ë ¤í•œ ì˜ˆì¸¡ì„ ì œê³µí•˜ì—¬ ì•½ë¬¼ ê°ì‹œ, ë‹¤ì•½ì œ ìœ„í—˜ í‰ê°€, ì •ë°€ ì˜í•™ì— ìœ ìš©í•œ ë„êµ¬ë¡œ ìë¦¬ì¡ì„ ìˆ˜ ìˆìŒì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. MPNP-DDIëŠ” ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ ê·¸ë˜í”„ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ í”„ë ˆì„ì›Œí¬ë¡œ, ì•½ë¬¼ ê°„ ìƒí˜¸ì‘ìš© ì˜ˆì¸¡ì˜ ì •í™•ì„±ì„ ë†’ì…ë‹ˆë‹¤.
- 2. ì´ í”„ë ˆì„ì›Œí¬ëŠ” ë©”ì‹œì§€ ì „ë‹¬ ë°©ì‹ì„ í†µí•´ ì—¬ëŸ¬ ìŠ¤ì¼€ì¼ì—ì„œ ê·¸ë˜í”„ í‘œí˜„ì˜ ê³„ì¸µ êµ¬ì¡°ë¥¼ í•™ìŠµí•©ë‹ˆë‹¤.
- 3. êµì°¨ ì•½ë¬¼ ê³µë™ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ì„ ì‚¬ìš©í•˜ì—¬ ë‹¤ì¤‘ ìŠ¤ì¼€ì¼ í‘œí˜„ì„ ë™ì ìœ¼ë¡œ ìœµí•©í•˜ê³ , ìƒí˜¸ì‘ìš©í•˜ëŠ” ì•½ë¬¼ ìŒì— ëŒ€í•œ ë¬¸ë§¥ ì¸ì‹ ì„ë² ë”©ì„ ìƒì„±í•©ë‹ˆë‹¤.
- 4. í†µí•©ëœ ì‹ ê²½ í”„ë¡œì„¸ìŠ¤ ëª¨ë“ˆì€ ì˜ˆì¸¡ì˜ ë¶ˆí™•ì‹¤ì„±ì„ ì •ëŸ‰í™”í•˜ëŠ” ê¸°ëŠ¥ì„ ì œê³µí•©ë‹ˆë‹¤.
- 5. MPNP-DDIëŠ” ë²¤ì¹˜ë§ˆí¬ ë°ì´í„°ì…‹ì—ì„œ ìµœì‹  ê¸°ë²•ë“¤ì„ ëŠ¥ê°€í•˜ë©°, ì•½ë¬¼ ê°ì‹œ, ë‹¤ì•½ì œ ìœ„í—˜ í‰ê°€, ì •ë°€ ì˜í•™ì— ê°•ë ¥í•œ ë„êµ¬ë¡œ í™œìš©ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.


---

*Generated on 2025-09-23 08:50:04*